Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

2013 trends

- PMLiVE

Shaping the Future of Hematology and Women’s Health

Changes in the healthcare world are likely to limit opportunities for young researchers, especially women.Three leaders in hematology — Belinda Avalos, Sarah O’Brien, and Marty Liggett — share the initiatives...

Medscape Education

- PMLiVE

BeiGene’s Tevimbra combination granted EC approval in small cell lung cancer

Approximately 15% of all lung cancer patients are diagnosed with the aggressive disease

- PMLiVE

Inizio Evoke appoints Tristen George and Kevin Kaniuga as executive creative directors

The dual appointments are aimed at strengthening Evoke’s creative leadership

- PMLiVE

AstraZeneca/Daiichi Sankyo share positive phase 3 results for Enhertu in early breast cancer

Around one in three patients with early-stage breast cancer are considered high risk

- PMLiVE

FDA announces rapid rollout of AI system to accelerate drug review process

The move follows the completion of a new AI-assisted scientific review pilot

The (clinical) trials and tribulations of gene therapy – why meaningful patient engagement strategies matter

By Sarah Mohamad and Lauren Coleman-Bennett

Amiculum

- PMLiVE

Apiary invests in life sciences performance marketing specialist performance-io

The investment will support the agency’s growth, service expansion and international presence

- PMLiVE

Tiziana Life Sciences’ intranasal MS candidate shows promise in open-label study

Approximately 2.9 million people worldwide are living with the neurodegenerative disease

- PMLiVE

The Weber Shandwick Collective appoints Lucie Harper as president of Health, UK

Harper has most recently been serving as president of integrated communications at Real Chemistry

- PMLiVE

Are Clinicians Still Feeling the Burn? A Look at HCP Mental Health and Well-Being

One of the most critical topics to address in health care today is the mental health and well-being of physicians and other healthcare professionals. The 2020 COVID-19 pandemic shined a...

Medscape Education

- PMLiVE

Eli Lilly and Alchemab Therapeutics enter ALS agreement worth up to $415m

The deal follows the companies’ earlier partnership to advance candidates for the neurodegenerative disease

- PMLiVE

Johnson & Johnson shares long-term results for Tremfya in ulcerative colitis

More than 2.5 million people in Europe are affected by the inflammatory bowel disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links